Comparison of transvaginal ultrasonography and magnetic resonance imaging in the evaluation of adenomyosis: A comparative study

In: International Journal of Clinical Obstetrics and Gynaecology · 2026 · vol. 10(5) , pp. 352–360 · doi:10.33545/gynae.2026.v10.i5e.2884 · W7212953813
Diagnostic accuracy OA: bronze CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-26 ⓘ

This comparative study found that magnetic resonance imaging demonstrated significantly higher sensitivity, accuracy, and agreement with histopathology than transvaginal ultrasonography for evaluating adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-08 · read from full text ⓘ

This comparative diagnostic study evaluated the accuracy of transvaginal ultrasonography and magnetic resonance imaging in detecting adenomyosis among 120 women scheduled for hysterectomy. Using histopathological examination of surgical specimens as the reference standard, researchers calculated sensitivity, specificity, and overall diagnostic accuracy for both imaging modalities. The results demonstrated that MRI achieved significantly higher sensitivity (94.1%) and diagnostic accuracy (94.2%) compared to transvaginal ultrasonography (83.8% and 84.2%, respectively), while also showing almost-perfect agreement with pathological findings. This paper is centrally about adenomyosis — specifically comparing the diagnostic performance of two primary imaging techniques against histopathology.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Adenomyosis is a benign uterine disorder that commonly presents with heavy menstrual bleeding, dysmenorrhoea, chronic pelvic pain and infertility. Although histopathological examination of hysterectomy specimens remains the reference standard, non-invasive imaging has become increasingly important for preoperative diagnosis. Transvaginal ultrasonography is widely used as a first-line investigation, whereas magnetic resonance imaging offers superior soft-tissue contrast and detailed evaluation of the uterine junctional zone. Aim: To compare the diagnostic performance of transvaginal ultrasonography and magnetic resonance imaging in the evaluation of adenomyosis. Materials and Methods: This hospital-based comparative cross-sectional diagnostic-accuracy study included 120 women with clinical suspicion of adenomyosis who underwent hysterectomy at a tertiary-care hospital. All participants were evaluated preoperatively using TVUS and pelvic MRI. Imaging findings were compared with histopathological examination of hysterectomy specimens as the reference standard. Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, diagnostic accuracy and diagnostic odds ratios were calculated with 95% confidence intervals. Agreement was assessed using Cohen’s kappa coefficient, and the paired diagnostic performance of TVUS and MRI was compared using the exact McNemar test. A p value <0.05 was considered statistically significant. Results: Histopathological examination confirmed adenomyosis in 68 (56.7%) of the 120 participants. TVUS correctly identified 57 true-positive and 44 true-negative cases, whereas MRI identified 64 true-positive and 49 true-negative cases. TVUS demonstrated sensitivity of 83.8%, specificity of 84.6%, positive predictive value of 87.7%, negative predictive value of 80.0% and diagnostic accuracy of 84.2%. The corresponding values for MRI were 94.1%, 94.2%, 95.5%, 92.5% and 94.2%, respectively. MRI had a higher positive likelihood ratio (16.31 versus 5.45), a lower negative likelihood ratio (0.06 versus 0.19) and a higher diagnostic odds ratio (261.33 versus 28.50). MRI showed almost-perfect agreement with histopathology (?=0.88; p<0.001), whereas TVUS showed substantial agreement (?=0.68; p<0.001). MRI demonstrated significantly higher sensitivity (p=0.039), lower false-negative rate (5.9% versus 16.2%; p=0.039) and greater overall diagnostic accuracy than TVUS (94.2% versus 84.2%; p=0.004). Conclusion: TVUS provided good diagnostic performance and remained a suitable first-line imaging modality for adenomyosis. MRI demonstrated higher sensitivity, accuracy and agreement with histopathology and produced fewer false-negative findings. MRI should be considered when TVUS findings are inconclusive or when detailed assessment of the extent of adenomyosis is required.
Full text 48,433 characters · extracted from oa-pdf · 13 sections · click to expand

Abstract

Background: Adenomyosis is a benign uterine disorder that commonly presents with heavy menstrual bleeding, dysmenorrhoea, chronic pelvic pain and infertility. Although histopathological examination of hysterectomy specimens remains the reference standard, non-invasive imaging has become increasingly important for preoperative diagnosis. Transvaginal ultrasonography is widely used as a first-line investigation, whereas magnetic resonance imaging offers superior soft-tissue contrast and detailed evaluation of the uterine junctional zone. Aim: To compare the diagnostic performance of transvaginal ultrasonography and magnetic resonance imaging in the evaluation of adenomyosis.

Materials and methods

This hos pital-based comparative cross-sectional diagnostic-accuracy study included 120 women with clinical suspicion of adenomyosis who underwent hysterectomy at a tertiary-care hospital. All participants were evaluated preoperatively using TVUS and pelvic MRI. Imaging findings were compared with histopathological examination of hysterectomy specimens as the reference standard. Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratios, diagnostic accuracy and diagnostic odds ratios were calculated with 95% confidence intervals. Agreement was assessed using Cohen’s kappa coefficient, and the paired diagnostic performance of TVUS and MRI was compared using the exact McNemar test. A p value <0.05 was considered statistically significant.

Results

Histopathological examination confirmed adenomyosis in 68 (56.7%) of the 120 participants. TVUS correctly identified 57 true-positive and 44 true-negative cases, whereas MRI identified 64 true- positive and 49 true-negative cases. TVUS demonstrated sensitivity of 83.8%, specificity of 84.6%, positive predictive value of 87.7%, negative predictive value of 80.0% and diagnostic accuracy of 84.2%. The corresponding values for MRI were 94.1%, 94.2%, 95.5%, 92.5% and 94.2%, respectively. MRI had a higher positive likelihood ratio (16.31 versus 5.45), a lower negative likelihood ratio (0.06 versus 0.19) and a higher diagnostic odds ratio (261.33 versus 28.50). MRI showed almost-perfect agreement with histopathology (κ=0.88; p<0.001), whereas TVUS showed substantial agreement (κ=0.68; p<0.001). MRI demonstrated significantly higher sensitivity (p=0.039), lower false-negative rate (5.9% versus 16.2%; p=0.039) and greater overall diagnostic accuracy than TVUS (94.2% versus 84.2%; p=0.004).

Conclusion

TVUS provided good diagnostic performance and remained a suitable first-line imaging modality for adenomyosis. MRI demonstrated higher sensitivity, accuracy and agreement with histopathology and produced fewer false-negative findings. MRI should be considered when TVUS findings are inconclusive or when detailed assessment of the extent of adenomyosis is required.

Keywords

Adenomyosis; Transvaginal ultrasonography; Magnetic resonance imaging.

Introduction

Adenomyosis is a benign uterine disorder characterised by the presence of endometrial glands and stroma within the myometrium, accompanied by hypertrophy and hyperplasia of the surrounding smooth muscle. It commonly affects women of reproductive and perimenopausal age and may present with heavy menstrual bleeding, progressive dysmenorrhoea, chronic pelvic pain, dyspareunia, infertility or an enlarged tender uterus. However, some patients remain asymptomatic. The clinical presentation frequently overlaps with uterine leiomyomas and endometriosis, making diagnosis based only on symptoms and pelvic examination difficult. Historically, adenomyosis was confirmed by histopathological examination of hysterectomy specimens. Increasing use of non-invasive imaging has facilitated preoperative diagnosis and the conservative management of women wishing to preserve fertility or avoid hysterectomy [1,2]. Transvaginal ultrasonography (TVUS) is generally used as the first-line imaging modality because it is widely available, relatively inexpensive, well tolerated and capable of providing ~ 353 ~ real-time assessment of the uterus. Sonographic features suggestive of adenomyosis include globular uterine enlargement, asymmetrical myometrial thickening, myometrial cysts, hyperechoic islands, fan -shaped shadowing, echogenic subendometrial lines and buds, translesional vascularity and an irregular or interrupted junctional zone. The Morphological Uterus Sonographic Assessment consensus has improved the terminology and standardisation of these findings [3,4]. Nevertheless, the diagno stic performance of TVUS remains dependent on operator experience, equipment quality and the presence of coexisting pelvic abnormalities. Magnetic resonance imaging (MRI) provides superior soft-tissue contrast, multiplanar assessment and improved visualisa tion of the uterine junctional zone. MRI findings associated with adenomyosis include junctional -zone thickening, an increased junctional-zone-to-myometrial thickness ratio, ill -defined areas of low signal intensity and small high -signal-intensity myometrial foci on T2 - or T1 -weighted images. MRI may be particularly useful when TVUS findings are inconclusive or when adenomyosis coexists with leiomyomas or endometriosis. However, MRI is more expensive, less accessible and contraindicated in certain patients. Available evidence suggests that both TVUS and MRI have good diagnostic performance, although results vary according to diagnostic criteria, examiner expertise and the reference standard employed [2,5]. A direct comparison of these modalities against hist opathological findings may help define their relative diagnostic value and guide appropriate imaging choices. Therefore, the present study compared TVUS and MRI in the evaluation of adenomyosis among women undergoing hysterectomy. Aim To compare the diag nostic performance of transvaginal ultrasonography and magnetic resonance imaging in the evaluation of adenomyosis.

Objectives

1. To determine the sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of transvaginal ultrasonography in detecting adenomyosis. 2. To determine the sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy of magnetic resonance imaging in detecting adenomyosis. 3. To compare the findings of t ransvaginal ultrasonography and magnetic resonance imaging with histopathological examination and assess their diagnostic agreement.

Material

and Methodology Source of Data The study participants were recruited from women attending the outpatient and inpatient services of the Department of Obstetrics and Gynaecology at a tertiary -care teaching hospital. Women who had symptoms or clinical findings suggestive of adenomyosis and who were scheduled to undergo hysterectomy were assessed for eligibility. Clinic al information, TVUS findings, MRI findings, operative observations and histopathological results were obtained from clinical examination records, radiological reports, operative notes and histopathology reports. Study Design A hospital -based comparative c ross-sectional diagnostic - accuracy study was conducted. Both TVUS and MRI were performed in the same participants, and the results of each imaging modality were compared with histopathological examination of hysterectomy specimens, which was considered the reference standard. Study Location The study was conducted jointly in the Departments of Obstetrics and Gynaecology, Radiodiagnosis and Pathology. Study Duration The study was conducted over 12 months. This period included participant recruitment, imagin g assessment, surgical management, histopathological examination, data collection and statistical analysis. Sample Size A total of 120 eligible women were included in the study. The sample size was estimated using the anticipated sensitivity of imaging fo r diagnosing adenomyosis, an expected prevalence among symptomatic women undergoing hysterectomy, a 95% confidence level and an acceptable absolute precision. It was calculated using the diagnostic-study formula: where at a 95% confidence level, represented the anticipated sensitivity, represented absolute precision and represented the anticipated prevalence of adenomyosis. After allowing for incomplete investigations or records, the final sample size was fixed at 120 participants. Consecutive eligible participants were recruited until the required sample size was achieved. Inclusion Criteria Women were included when they:  Were aged 18 years or older.  Presented with symptoms or clinical findings sugges tive of adenomyosis, such as heavy menstrual bleeding, dysmenorrhoea, chronic pelvic pain, dyspareunia or a bulky tender uterus.  Were scheduled to undergo hysterectomy as part of their clinical management.  Underwent both TVUS and pelvic MRI before surgery.  Provided written informed consent to participate in the study.  Had histopathological examination of the hysterectomy specimen available for comparison. Exclusion Criteria Women were excluded when they:  Were pregnant or suspected to be pregnant.  Had contraindications to MRI, including non -compatible metallic implants, cardiac pacemakers or severe claustrophobia.  Were unwilling or unable to undergo TVUS.  Had previously undergone endometrial ablation, uterine artery embolisation or conservative surge ry for adenomyosis.  Had received hormonal treatment that could substantially International Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com ~ 354 ~ alter imaging findings during the preceding three months.  Had a known or suspected uterine, cervical or ovarian malignancy.  Had technically inadequate TVUS or MRI examinations.  Did not undergo hysterectomy or had an unavailable/inadequate specimen for histopathological examination.  Declined participation or had incomplete essential study data.  Procedure and Methodology Approval was obtained from the Institutional Ethics Comm ittee before commencing the study. Written informed consent was obtained from every participant. Confidentiality of patient information was maintained throughout the study. A detailed history was recorded, including age, parity, menstrual pattern, heavy me nstrual bleeding, severity and duration of dysmenorrhoea, chronic pelvic pain, dyspareunia, infertility, previous caesarean delivery, uterine surgery and hormonal treatment. General, abdominal and pelvic examinations were performed. Relevant laboratory findings, including haemoglobin concentration, were documented. Transvaginal ultrasonography TVUS was performed using a high -frequency endovaginal transducer, preferably during the early proliferative phase when clinically feasible. The urinary bladder was e mptied before examination. The uterus was assessed in sagittal and transverse planes for its position, dimensions, volume, shape, symmetry of the uterine walls, myometrial echotexture and associated pelvic abnormalities. Adenomyosis was suspected when one or more recognised MUSA features were identified, including:  Myometrial cysts;  Hyperechoic islands;  Echogenic subendometrial lines or buds;  Fan-shaped acoustic shadowing;  Globular uterine configuration;  Asymmetrical myometrial thickening;  Translesional vascularity;  An irregular or interrupted junctional zone. Direct and indirect features were recorded separately. The location and extent of suspected adenomyosis, involvement of the inner or outer myometrium and the presence of focal or diffuse disea se were documented. Associated leiomyomas, endometriosis or adnexal pathology were also recorded. The TVUS examiner recorded the final impression as adenomyosis present or absent. Magnetic resonance imaging Pelvic MRI was performed using a 1.5 -Tesla or 3 -Tesla MRI system with a phased -array pelvic coil. The standard protocol included multiplanar T2 -weighted sequences and axial T1 - weighted sequences, with fat -suppressed sequences wherever required. Contrast-enhanced imaging was performed only when clinically indicated. MRI evaluation included uterine size and configuration, myometrial signal intensity, maximum junctional -zone thickness, junctional -zone irregularity, the ratio of maximum junctional-zone thickness to total myometrial thickness and the presence of small high -signal-intensity myometrial foci. Adenomyosis was diagnosed when characteristic features such as junctional-zone thickening, an ill-defined low-signal-intensity myometrial area or punctate high -signal-intensity foci were identified. The dise ase was classified as focal or diffuse and its location and extent were recorded. Whenever feasible, the radiologist interpreting the MRI was blinded to the detailed TVUS interpretation, and the imaging specialists were blinded to the final histopathologic al findings. The interval between imaging and surgery was kept as short as practically possible, preferably within four weeks. Following imaging, the participants underwent hysterectomy according to their clinical indications and institutional treatment protocols. The decision to perform surgery was made by the treating clinician and was independent of participation in the study. Sample Processing Immediately after hysterectomy, the uterus was labelled with a unique identification number and transported to the Department of Pathology in 10% neutral -buffered formalin. Gross examination included uterine dimensions, external appearance, endometrial cavity, myometrial thickness, areas of haemorrhage, cystic changes, trabeculation and coexisting leiomyomas or other lesions. Representative tissue sections were obtained from the anterior and posterior uterine walls, fundus, cornual regions and any grossly suspicious myometrial area. The tissue was processed routinely, embedded in paraffin, sectioned at approximatel y 3-5 µm and stained with haematoxylin and eosin. Adenomyosis was diagnosed histopathologically by the presence of endometrial glands and stroma within the myometrium, accompanied by surrounding smooth -muscle hypertrophy or hyperplasia. The pathologist was blinded, as far as feasible, to the final imaging diagnosis. Histopathological findings were categorised as adenomyosis present or absent and were used as the reference standard. Statistical Methods Data were entered into Microsoft Excel and analysed usi ng IBM SPSS Statistics or an equivalent statistical package. Continuous variables were assessed for normality using the Shapiro -Wilk test and graphical methods. Normally distributed variables were summarised as mean and standard deviation with 95% confidence intervals, whereas skewed variables were reported as median and interquartile range. Categorical variables were presented as frequencies and percentages. The diagnostic performances of TVUS and MRI were calculated against histopathology in terms of:  Sensitivity;  Specificity;  Positive predictive value;  Negative predictive value;  False-positive and false-negative rates;  Overall diagnostic accuracy;  Positive and negative likelihood ratios. All diagnostic estimates were reported with 95% confidence intervals. The chi -square test or Fisher’s exact test was used to assess associations between categorical variables. Because TVUS and MRI results were obtained from the same participants, their paired proportions, including sensitivity, specificity and over all accuracy, were compared using McNemar’s test. Agreement between each imaging modality and histopathology was assessed using Cohen’s kappa coefficient. International Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com ~ 355 ~ Receiver operating characteristic curves were constructed for relevant continuous imaging measurement s, such as junctional - zone thickness. The area under the curve and its 95% confidence interval were calculated, and an appropriate diagnostic cut -off was identified using the Youden index. A two -sided p value <0.05 was considered statistically significant. Data Collection Data were collected using a predesigned, pretested and structured case -record form. The form contained the following sections:  Sociodemographic details;  Obstetric and menstrual history;  Presenting symptoms and their duration;  Previous medical, hormonal and surgical history;  General and pelvic examination findings;  TVUS characteristics and diagnostic impression;  MRI characteristics and diagnostic impression;  Operative details;  Gross pathological findings;  Final histopathological diagnosis. Each participant was assigned a unique study code. The completed forms were checked regularly for accuracy, consistency and completeness. Data were entered into a password-protected electronic database, and participant identifiers were removed before statistical analysis. Observation and Results Table 1: Comparison of the diagnostic performance of TVUS and MRI for adenomyosis (N=120) Diagnostic parameter TVUS, n/N (%) 95% CI MRI, n/N (%) 95% CI Test of significance p value Sensitivity 57/68 (83.8) 73.3-90.7 64/68 (94.1) 85.8-97.7 Exact McNemar test 0.039 Specificity 44/52 (84.6) 72.5-92.0 49/52 (94.2) 84.4-98.0 Exact McNemar test 0.125 Positive predictive value 57/65 (87.7) 77.5-93.6 64/67 (95.5) 87.6-98.5 Difference=7.8% 0.103 Negative predictive value 44/55 (80.0) 67.6-88.4 49/53 (92.5) 82.1-97.0 Difference=12.5% 0.061 Diagnostic accuracy 101/120 (84.2) 76.6-89.6 113/120 (94.2) 88.4-97.1 Exact McNemar test 0.004 False-positive rate 8/52 (15.4) 8.0-27.5 3/52 (5.8) 2.0-15.6 Exact McNemar test 0.125 False-negative rate 11/68 (16.2) 9.3-26.7 4/68 (5.9) 2.3-14.2 Exact McNemar test 0.039 Positive likelihood ratio 5.45 2.88-10.31 16.31 5.44-48.88 Negative likelihood ratio 0.19 0.11-0.34 0.06 0.02-0.15 Diagnostic odds ratio 28.50 10.57-76.86 261.33 55.88-1222.08 Table 1 compares the diagnostic performance of TVUS and MRI for detecting adenomyosis among 120 participants. MRI demonstrated significantly greater sensitivity than TVUS (94.1% versus 83.8%; p=0.039). Although MRI also showed higher specificity (94.2% versus 84.6%), the difference was not statistically significant (p=0.125). The positive predictive value was 95.5% for MRI and 87.7% for TVUS (p=0.103), while the corresponding negative predictive values were 92.5% and 80.0% (p=0.061). MRI achieved significantly higher overall diagnostic accuracy than TVUS (94.2% versus 84.2%; p=0.004). MRI also had lower false -positive (5.8% versus 15.4%; p=0.125) and significantly lower false -negative rates (5.9% versus 16.2%; p=0.039). F urthermore, MRI had a higher positive likelihood ratio (16.31 versus 5.45), a lower negative likelihood ratio (0.06 versus 0.19) and a substantially higher diagnostic odds ratio (261.33 versus 28.50), indicating superior diagnostic performance. A. TVUS-histopathology cross-classification Table 2: Diagnostic performance of TVUS for detecting adenomyosis using histopathology as the reference standard (N=120) TVUS finding Histopathology positive, n (%) Histopathology negative, n (%) Total, n (%) Positive for adenomyosis 57 (47.5) True positive 8 (6.7) False positive 65 (54.2) Negative for adenomyosis 11 (9.2) False negative 44 (36.7) True negative 55 (45.8) Total 68 (56.7) 52 (43.3) 120 (100.0) Association between TVUS and histopathological diagnosis: χ²=55.59, p<0.001. B. Diagnostic indices of TVUS Diagnostic index Estimate 95% CI Test statistic p value Sensitivity 83.8% 73.3-90.7 Specificity 84.6% 72.5-92.0 Positive predictive value 87.7% 77.5-93.6 Negative predictive value 80.0% 67.6-88.4 Diagnostic accuracy 84.2% 76.6-89.6 Positive likelihood ratio 5.45 2.88-10.31 Negative likelihood ratio 0.19 0.11-0.34 Diagnostic odds ratio 28.50 10.57-76.86 χ²=55.59 <0.001 Agreement with histopathology κ=0.68 0.55-0.81 Z=7.47 <0.001 Table 2 presents the diagnostic performance of TVUS using histopathology as the reference standard. Histopathological examination confirmed adenomyosis in 68 (56.7%) participants and excluded it in 52 (43.3%). TVUS correctly identified 57 International Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com ~ 356 ~ true-positive cases and 44 true-negative cases, while producing 8 false-positive and 11 false -negative results. TVUS had a sensitivity of 83.8% (95% CI: 73.3 -90.7), specificity of 84.6% (95% CI: 72.5 -92.0), positive predictive value of 87.7% (95% CI: 77.5 -93.6), negative predictive value of 80.0% (95% CI: 67.6-88.4) and overall diagnostic accuracy of 84.2% (95% CI: 76.6-89.6). Its positive and negative likelihood ratios were 5.45 and 0.19, respectively. The diagnostic odds ratio was 28.50 (95% CI: 10.57 -76.86), and the association between TVUS and histopathological diagnosis was statistically significant (χ²=55.59, p<0.001). TVUS also demonstrated substantial agreement with histopathology (κ=0.68; 95% CI: 0.55 -0.81; Z=7.47; p<0.001). A. MRI-histopathology cross-classification Table 3: Diagnostic performance of MRI for detecting adenomyosis using histopathology as the reference standard (N=120) MRI finding Histopathology positive, n (%) Histopathology negative, n (%) Total, n (%) Positive for adenomyosis 64 (53.3) True positive 3 (2.5) False positive 67 (55.8) Negative for adenomyosis 4 (3.3) False negative 49 (40.8) True negative 53 (44.2) Total 68 (56.7) 52 (43.3) 120 (100.0) Association between MRI and histopathological diagnosis: χ²=93.27, p<0.001. B. Diagnostic indices of MRI Diagnostic index Estimate 95% CI Test statistic p value Sensitivity 94.1% 85.8-97.7 Specificity 94.2% 84.4-98.0 Positive predictive value 95.5% 87.6-98.5 Negative predictive value 92.5% 82.1-97.0 Diagnostic accuracy 94.2% 88.4-97.1 Positive likelihood ratio 16.31 5.44-48.88 Negative likelihood ratio 0.06 0.02-0.15 Diagnostic odds ratio 261.33 55.88-1222.08 χ²=93.27 <0.001 Agreement with histopathology κ=0.88 0.78-0.98 Z=9.66 <0.001 Table 3 shows the diagnostic performance of MRI using histopathological examination as the reference standard. MRI correctly identified 64 of the 68 histopathologically positive cases and 49 of the 52 histopathologically negative cases. Only 3 false-positive and 4 false -negative results were observed. MRI demonstrated a sensitivity of 94.1% (95% CI: 85.8 -97.7), specificity of 94.2% (95% CI: 84.4 -98.0), positive predictive value of 95.5% (95% CI: 87.6 -98.5), negative predictive value of 92.5% (95% CI: 82.1-97.0) and diagnostic accuracy of 94.2% (95% CI: 88.4 -97.1). The positive likelihood ratio was 16.31, whereas the negative likelihood ratio was 0.06. The diagnostic odds ratio was 261.33 (95% CI: 55.88 -1222.08), and MRI findings were significantly associated with histopathological diagnosis (χ²=93.27, p<0.001). MRI demonstrated almost - perfect agreement with histopathology (κ=0.88; 95% CI: 0.78 - 0.98; Z=9.66; p<0.001). A. Agreement of each imaging modality with histopathology Table 4: Agreement and paired comparison of TVUS and MRI findings with histopathology (N=120) Comparison Observed agreement, n/N (%) 95% CI Cohen’s κ 95% CI for κ Strength of agreement Test statistic p value TVUS versus histopathology 101/120 (84.2) 76.6-89.6 0.68 0.55-0.81 Good/substantial Z=7.47 <0.001 MRI versus histopathology 113/120 (94.2) 88.4-97.1 0.88 0.78-0.98 Almost perfect Z=9.66 <0.001 TVUS versus MRI diagnosis 104/120 (86.7) 79.4-91.6 0.73 0.61-0.85 Good/substantial Z=8.03 <0.001 B. Paired comparison of correctly classified cases TVUS classification MRI correct, n (%) MRI incorrect, n (%) Total, n (%) TVUS correct 99 (82.5) 2 (1.7) 101 (84.2) TVUS incorrect 14 (11.7) 5 (4.2) 19 (15.8) Total 113 (94.2) 7 (5.8) 120 (100.0) Exact McNemar test comparing overall diagnostic accuracy: p=0.004. C. Summary of paired diagnostic differences Diagnostic comparison TVUS MRI Absolute difference Test p value Correctly classified cases 101 (84.2%) 113 (94.2%) +10.0 percentage points Exact McNemar 0.004 Histopathology-positive cases detected 57/68 (83.8%) 64/68 (94.1%) +10.3 percentage points Exact McNemar 0.039 Histopathology-negative cases correctly excluded 44/52 (84.6%) 49/52 (94.2%) +9.6 percentage points Exact McNemar 0.125 False-negative cases 11/68 (16.2%) 4/68 (5.9%) −10.3 percentage points Exact McNemar 0.039 False-positive cases 8/52 (15.4%) 3/52 (5.8%) −9.6 percentage points Exact McNemar 0.125 International Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com ~ 357 ~ Table 4 demonstrates the agreement and paired comparison of TVUS and MRI with histopathological findings. TVUS agreed with histopathology in 101 of 120 cases, producing an observed agreement of 84.2% (95% CI: 76.6 -89.6) and substantial agreement beyond chance (κ=0.68; p<0.001). MRI agreed with histopathology in 113 cas es, corresponding to an observed agreement of 94.2% (95% CI: 88.4 -97.1) and almost -perfect agreement (κ=0.88; p<0.001). Agreement between TVUS and MRI diagnoses was 86.7% (κ=0.73; 95% CI: 0.61 -0.85; p<0.001). Both modalities correctly classified 99 (82.5%) cases; however, MRI correctly classified 14 cases that were incorrectly classified by TVUS, whereas TVUS correctly classified only 2 cases that were incorrectly classified by MRI. Consequently, MRI showed significantly higher overall accuracy than TVUS (94.2% versus 84.2%; exact McNemar p=0.004). MRI detected 10.3 percentage points more histopathology -positive cases (p=0.039) and reduced the false-negative rate by 10.3 percentage points (p=0.039). Although MRI also correctly excluded 9.6 percentage points more disease-negative cases and reduced the false-positive rate by 9.6 percentage points, these differences were not statistically significant (p=0.125).

Discussion

In the present comparative study of 120 women, histopathological examination confirmed ade nomyosis in 68 (56.7%) participants. Both transvaginal ultrasonography (TVUS) and magnetic resonance imaging (MRI) demonstrated good diagnostic performance; however, MRI consistently produced higher sensitivity, specificity, predictive values, diagnostic accuracy and agreement with histopathology. The improved performance of MRI was particularly evident in its lower false - negative rate and significantly higher overall diagnostic accuracy. These findings support the use of TVUS as the initial imaging investi gation and MRI as a valuable second -line or problem-solving modality, especially when TVUS findings are inconclusive or complex coexisting uterine pathology is present. Comparison of TVUS and MRI diagnostic performance The sensitivity of MRI in the presen t study was significantly higher than that of TVUS (94.1% versus 83.8%; p=0.039). MRI also showed higher specificity (94.2% versus 84.6%), although this difference was not statistically significant (p=0.125). Similarly, MRI demonstrated higher positive and negative predictive values than TVUS. The overall diagnostic accuracy was 94.2% for MRI compared with 84.2% for TVUS, representing a significant absolute improvement of 10 percentage points (p=0.004). Van den Bosch et al . (2015) [1] developed the Morpholo gical Uterus Sonographic Assessment terminology to standardise the reporting of myometrial and junctional -zone abnormalities. Their consensus identified myometrial cysts, hyperechoic islands, fan -shaped shadowing, asymmetrical myometrial thickening, transl esional vascularity and junctional -zone irregularity as important sonographic features of adenomyosis. Consistent application of these criteria may explain the relatively high TVUS sensitivity observed in the present study. Pinzauti et al . (2015) [2] reported that TVUS performed by experienced examiners could reliably identify adenomyosis before surgery. However, they also emphasised that diagnostic performance depended on examiner expertise and the presence of coexisting uterine lesions. Bazot and Daraï (2018) [3] similarly observed that TVUS and MRI were the principal non -invasive diagnostic modalities, with MRI providing superior tissue characterisation and more objective evaluation of the junctional zone. In a systematic review and meta-analysis, Andres et al. (2018) [4] concluded that TVUS had good diagnostic performance and could be used as a first -line investigation for adenomyosis. However, variation in individual sonographic criteria and operator experience contributed to heterogeneity across studies . Liu et al . (2019) [5] compared commonly used diagnostic approaches and found that both TVUS and MRI had clinically useful accuracy, although MRI generally showed greater specificity. This is consistent with the present finding of 94.2% specificity for MRI compared with 84.6% for TVUS. Tellum et al . (2020) [6] found comparable overall diagnostic ability for TVUS and MRI in their meta -analysis, but MRI showed an advantage in specificity and in diagnostically difficult cases. Chapron et al . (2020) [7] recommended an integrated clinical and imaging approach and observed that expert TVUS could perform well, while MRI was helpful for lesion mapping, disease classification and assessment of the junctional zone. The present findings similarly demonstrated that bot h modalities were diagnostically useful, although MRI achieved significantly higher accuracy. The higher MRI performance in this study could be attributed to its superior soft-tissue contrast, multiplanar capability and ability to demonstrate junctional -zone thickening, myometrial signal abnormalities and small haemorrhagic or cystic foci. By contrast, TVUS performance may be influenced by uterine position, obesity, coexisting leiomyomas and operator interpretation. Harmsen et al . (2022) [8] revised the MUS A definitions by dividing sonographic signs into direct and indirect features, thereby improving their clinical interpretation and reproducibility. Application of these revised criteria may further improve future TVUS performance. Diagnostic performance of TVUS TVUS correctly detected 57 of the 68 histopathologically confirmed cases and correctly excluded disease in 44 of the 52 histopathology-negative participants. It produced 8 false-positive and 11 false -negative findings. Its sensitivity was 83.8%, specificity 84.6%, positive predictive value 87.7%, negative predictive value 80.0% and diagnostic accuracy 84.2%. The diagnostic odds ratio was 28.50, and TVUS demonstrated substantial agreement with histopathology (κ=0.68, p<0.001). The TVUS sensitivity obs erved in this study was higher than some pooled estimates reported by Andres et al. (2018) [4] and Tellum et al . (2020) [6]. This may reflect differences in study populations, prevalence, sonographer expertise, equipment quality and the number of sonograph ic criteria required for diagnosis. Studies limited to women undergoing hysterectomy may also contain a higher proportion of advanced or diffuse adenomyosis, in which ultrasonographic features are more apparent. Vannuccini et al . (2017) [9] explained that adenomyosis may occur in diffuse, focal or mixed forms and is frequently associated with smooth -muscle hypertrophy and disruption of the endometrial -myometrial junction. These variable pathological patterns may explain false-negative TVUS findings, particularly in early or focal disease. Abbott (2017) [10] also noted that adenomyosis is a heterogeneous disorder and that variations in diagnostic criteria contribute to inconsistencies between imaging and histopathology. Exacoustos et al. (2020) [11] demonstrated that the number and type of ultrasound features were associated with the severity and distribution of adenomyosis. Direct signs, such as myometrial cysts and hyperechoic islands, were generally more specific, International Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com ~ 358 ~ whereas indirect signs, such as a globular uterus and asymmetrical wall thickening, could also occur with leiomyomas or other myometrial disorders. This could explain the eight false- positive TVUS findings in the present study. Tellum et al. (2020) [12] reported that individual ultrasound signs did not have uniform diagnostic value and that combining several features improved diagnostic confidence. Rasmussen et al. (2019) [13] similarly found that interobserver agreement differed across ultrasonographic features, indicating that examiner training and standardised reporting are essential. In the present study, the positive likelihood ratio of 5.45 indicated that a positive TVUS result produced a moderate increase in the probability of adenomyosis, while the negative likelihood ratio of 0.19 showed tha t a negative examination substantially reduced but did not completely exclude the disease. The substantial agreement between TVUS and histopathology (κ=0.68) suggests that TVUS was clinically reliable but not interchangeable with the reference standard. Va n den Bosch et al. (2019) [14] highlighted that structured assessment of the myometrium and junctional zone could improve diagnostic reproducibility. Therefore, TVUS remains an appropriate first - line modality because it is inexpensive, widely available and provides real -time assessment without radiation exposure. Nevertheless, negative TVUS findings should be interpreted cautiously when clinical suspicion remains high. Diagnostic performance of MRI MRI correctly identified 64 of the 68 histopathologically positive cases and correctly excluded adenomyosis in 49 of the 52 disease -negative participants. Only 3 false -positive and 4 false-negative findings were recorded. MRI demonstrated sensitivity of 94.1%, specificity of 94.2%, positive predictive value of 95 .5%, negative predictive value of 92.5% and overall diagnostic accuracy of 94.2%. Its positive likelihood ratio was 16.31, negative likelihood ratio was 0.06 and diagnostic odds ratio was 261.33. These findings indicated that MRI was highly effective for both confirming and excluding adenomyosis. Agostinho et al . (2017) [15] described MRI as a highly useful modality for evaluating adenomyosis because of its ability to identify junctional -zone thickening, ill -defined low -signal- intensity areas and high -signal-intensity myometrial foci. The authors also cautioned that junctional -zone thickness could be influenced by age, menstrual phase, hormonal status and transient uterine contractions. These factors could account for occasional false-positive or false-negative MRI findings. Bazot and Daraï (2018) [3] reported that MRI was especially valuable when ultrasonographic findings were equivocal or when adenomyosis coexisted with uterine leiomyomas. The high MRI specificity in the present study supports this observat ion. Tellum et al. (2020) [6] also found that MRI generally provided higher specificity than TVUS, although pooled sensitivity estimates varied across studies. Moawad et al . (2022) [16] observed that MRI offered more

Objective

evaluation of the junctional zone and better definition of focal versus diffuse adenomyosis. They recommended MRI when TVUS was inconclusive, when coexisting pathology was suspected or when detailed mapping was needed before fertility - preserving treatment. Harmsen et al. (2023) [17] emphasised that the junctional zone is defined differently on TVUS, MRI and histology. This lack of direct anatomical equivalence may contribute to disagreement among modalities, even when examinations are performed correctly. Dason et al . (2023) [18] recommended TVUS as the initial investigation for suspected adenomyosis and MRI as a second - line modality when additional characterisation was required. The present results support this sequential approach but also indicate that MRI may be preferable when avoiding a missed diagnosis is clinically important. The MRI positive likelihood ratio of 16.31 provided strong evidence for confirming adenomyosis, whereas its negative likelihood ratio of 0.06 indicated that a negative MRI result made the disease highly unlikely. Mishra et al . (2023) [19] reported that MRI demonstrated high concordance with histopathology, particularly when junctional - zone measurements were combined with myometrial signal abnormalities. Similarly, the present study recorded almost - perfect MRI -histopathology agreement (κ=0.88). Nevertheless, MRI should not be considered infallible because mild superficial adenomyosis and small isolated foci may remain below spatial resolution, while uterine contractions can sometimes simulate focal junctional-zone thickening. Agreement with histopathology and paired diagnostic comparison TVUS agreed with histopathology in 84.2% of cases and demonstrated substantial agreement (κ=0.68). MRI agreed with histopathology in 94.2% and demonstrated almost -perfect agreement (κ=0.88). Agreement between TVUS and MRI was 86.7% (κ=0.73). Thus, the modalities generally classified the same participants similarly, but MRI showed closer concordance with the histopathological diagnosis. In the paired analysis, MRI correctly classi fied 14 cases that were incorrectly classified by TVUS, whereas TVUS correctly classified only 2 cases missed by MRI. MRI detected an additional 10.3% of histopathology -positive cases and significantly reduced the false-negative rate from 16.2% to 5.9% (p=0.039). Its improvement in specificity and false -positive rate did not reach statistical significance, possibly because only 52 participants were histopathologically negative. Kho et al. (2021) [20] described adenomyosis as a heterogeneous condition for which histopathological confirmation itself may be influenced by the number and location of tissue sections examined. Consequently, imaging -histopathology disagreement may partly reflect differences in sampling rather than imaging failure alone. Kobayashi et al. (2021) [21] further demonstrated that early and advanced pathological subtypes possess different morphological appearances, potentially affecting detection by both TVUS and MRI. Munro (2019) [22] noted that imaging -based diagnosis has become increasingly important because hysterectomy specimens are unavailable in women undergoing conservative management. The substantial agreement observed for TVUS supports its role in routine screening and initial evaluation. Nevertheless, the almost-perfect MRI agreem ent and significantly lower false - negative rate suggest that MRI offers added value in women with persistent symptoms, inconclusive TVUS, coexisting leiomyomas, suspected focal disease or planned conservative surgery.

Conclusion

Both transvaginal ultrason ography and magnetic resonance imaging were effective non -invasive modalities for evaluating adenomyosis. TVUS demonstrated good sensitivity, specificity and substantial agreement with histopathology, supporting its use as an accessible and cost -effective first-line investigation. However, MRI showed significantly higher sensitivity and overall diagnostic accuracy, stronger agreement with histopathology and a lower false -negative rate. MRI may therefore be particularly valuable when TVUS findings are International Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com ~ 359 ~ inconclusive, coexisting uterine abnormalities are present or accurate disease mapping is required. A sequential approach involving initial TVUS followed by MRI in selected patients may provide reliable and efficient diagnosis of adenomyosis.

Limitations

1. The study was conducted at a single tertiary -care hospital, which may limit the generalisability of the findings to other healthcare settings. 2. The sample size of 120 participants was relatively modest, particularly for subgroup analyses based on focal or diffus e adenomyosis. 3. Only women who underwent hysterectomy and had an available histopathological diagnosis were included. This may have introduced selection or verification bias and increased the proportion of women with severe symptoms or advanced disease. 4. The diagnostic performance observed in this surgical population may not be directly applicable to younger women, asymptomatic women or those receiving conservative treatment. 5. TVUS is operator -dependent; therefore, its diagnostic performance may have been i nfluenced by the experience and expertise of the examining sonographer. 6. MRI interpretation may have been affected by variations in menstrual-cycle phase, junctional -zone appearance, transient uterine contractions and coexisting leiomyomas. 7. Complete blind ing between clinical information and imaging findings might not have been possible in every participant, creating a possibility of observer bias. 8. Interobserver and intraobserver variability in TVUS, MRI and histopathological interpretation was not evaluated. 9. The diagnostic performances of individual MUSA sonographic features and separate MRI criteria were not analysed. 10. The study did not assess the cost -effectiveness, accessibility, examination time or patient acceptability of TVUS and MRI. Conflict of Interest Not available Financial Support Not available

References

1. Van den Bosch T, Dueholm M, Leone FPG, Valentin L, Rasmussen CK, Votino A, et al . Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment group. Ultrasound Obstet Gynecol. 2015;46(3):284-298. 2. Pinzauti S, Lazzeri L, Tosti C, Centini G, Orlandini C, Luisi S, et al . Transvaginal sonographic features of diffuse adenomyosis in 18 -30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015;46(6):730-736. 3. Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018;109(3):389-397. 4. Andres MP, Borrelli GM, Ribeiro J, Baracat EC, Abrão MS, Kho RM. Transvaginal ultrasound for the diagnosis of adenomyosis: systematic review and meta-analysis. J Minim Invasive Gynecol. 2018;25(2):257-264. 5. Liu L, Li W, Leonardi M, Condous G, Da Silva Costa F, Mol BW, et al . Diagnostic accuracy of transvaginal ultrasound and magnetic resonance imaging for adenomyosis: systematic review and meta-analysis. J Ultrasound Med. 2019;38(12):3311-3324. 6. Tellum T, Nygaard S, Lieng M. Noninvasive diagnosis of adenomyosis: a structured review and meta -analysis of diagnostic accuracy in imaging. J Minim Invasive Gynecol. 2020;27(2):408-418.e3. 7. Chapron C, Vannuccini S, Santulli P, Abrão MS, Carmona F, Fraser IS, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020;26(3):392-411. 8. Harmsen MJ, Van den Bosch T, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment features of adenomyosis: results of a modified Delphi procedure. Ultrasound Obstet Gynecol. 2022;60(1):118-131. 9. Vannuccini S, Tosti C, Carmona F, Huang SJ, Chapron C, Guo SW, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592-601. 10. Abbott JA. Adenomyosis and abnormal uterine bleeding: review of the evidence. Best Pract Res Clin Obstet Gynaecol. 2017;40:68-81. 11. Exacoustos C, Morosetti G, Conway F, Camilli S, Martire FG, Lazzeri L, et al . New sonographic classification of adenomyosis: do type and degree of adenomyosis correlate to severity of symptoms? J Minim Invasive Gynecol. 2020;27(6):1308-1315. 12. Tellum T, Matic GV, Dorm agen JB, Nygaard S, Viktil E, Qvigstad E, et al . Diagnosing adenomyosis with MRI: a prospective study revisiting the junctional -zone-thickness cutoff of 12 mm as a diagnostic marker. Eur Radiol. 2019;29(12):6971-6981. 13. Rasmussen CK, Hansen ES, Dueholm M. In ter-rater agreement in the diagnosis of adenomyosis by two - and three-dimensional transvaginal ultrasonography. Ultrasound Obstet Gynecol. 2019;54(4):512-518. 14. Van den Bosch T, de Bruijn AM, de Leeuw RA, Dueholm M, Exacoustos C, Valentin L, et al . Sonograph ic classification and reporting system for diagnosing adenomyosis. Ultrasound Obstet Gynecol. 2019;53(5):576 - 582. 15. Agostinho L, Cruz R, Osório F, Alves J, Setúbal A, Guerra A. MRI for adenomyosis: a pictorial review. Insights Imaging. 2017;8(6):549-556. 16. Moawad G, Fruscalzo A, Youssef Y, Kheil M, Tawil T, Nehme J, et al . Adenomyosis: an updated review on diagnosis and classification. J Clin Med. 2022;11(16):4828. 17. Harmsen MJ, Trommelen LM, de Leeuw RA, Tellum T, Juffermans LJM, Van den Bosch T, et al. Uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology. Ultrasound Obstet Gynecol. 2023;62(1):42-60. 18. Dason ES, Maxim M, Sanders AP, Papillon -Smith J, Thiel JA. Guideline No. 437: diagnosis and management of adenomyosis. J Obstet Gynaecol Can. 2023;45(6):417 - 429.e1. 19. Mishra P, Dash S, Jena SK, Behera S. Comparison of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis of adenomyosis with histopathological correlation. J Obstet Gynaecol India. International Journal of Clinical Obstetrics and Gynaecology https://www.gynaecologyjournal.com ~ 360 ~ 2023;73(4):342-349. 20. Kho KA, Chen JS, Halvorson LM. Diagnosis, evaluation, and treatment of adenomyosis. JAMA. 2021;326(2):177 - 178. 21. Kobayashi H, Matsubara S, Imanaka S. Clinicopathological features of different subtypes in adenomyosis: focus on early lesions. PLoS One. 2021;16(7). 22. Munro MG. Classification and reporting systems for adenomyosis. J Minim Invasive Gynecol. 2019;26(2):197 - 199. How to Cite This Article Reddy NA, Alluri DR, Reddy GH. Comparison of transvaginal ultrasonography and magnetic resonance ima ging in the evaluation of adenomyosis: A comparative study . International Journal of Clinical Obstetrics and Gynaecology. 2026;10(5):352-360. Creative Commons (CC) License This is an open access journal, and articles are distributed under the terms of the C reative Commons Attribution -Non-Commercial-Share Alike 4.0 International (CC BY -NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non -commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (18)

Source provenance

openalex
last seen: 2026-11-18T06:02:33.299327+00:00
License: CC0 · commercial use OK